Infectious diseases are one of the leading causes of morbidity and mortality across the globe. Diagnostics is the primary step for the disease discovery and treatment leading to eradication of infectious diseases. Owing to ever-evolving pathogens and emerging new diseases, there is dire need to identify suitable diagnostics technique that can help physicians to decide appropriate treatment. This can also help to control the outbreak of the disease in the population. Technological advancement has rapidly changed the landscape of infectious disease diagnostics. Scientific research and development activities in novel technologies and technique such as mass spectrometry and next-generation sequencing (NGS) are changing the way how rapid diagnostics are being performed to detect diseases. In addition, growing inclination of end-user towards point-of-care testing is also anticipated to drive the industry growth. The point-of-care diagnostics provide rapid actionable information for patients care at the real-time and site of an encounter with the healthcare system. Additionally, various major players are focused on research and development activities to develop point-of-care diagnostics solution for developing countries.
Key Market Trends
Viral Infection diagnostics are expected to cover a large share of the market
A viral infection is one of the major public health concerns around the world. As per a report by Meryem Jefferies et al. published in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Furthermore, according to the World Health Organization, 37.9 million people were living with HIV/AIDS worldwide in 2018. Moreover, an estimated 32 million people have died of HIV.
Thus, owing to the high prevalence of these dreadful illnesses, the demand for early diagnostic tests is expected to increase as early diagnosis may reduce the spread of the disease. Hence, this market is expected to increase in the future.
North America is expected to Hold Largest Market Share
According to Charbel el Bcheraoui et al. published in the Journal of the American Medical Association 2018, between 1980 and 2014, there were more than 4 million deaths due to infectious diseases recorded in the United States. In 2014, a total of more than 110,000 deaths (a rate of 34.10 deaths per 100?000 persons) were due to infectious diseases in the United States.
As United States is developed economy, it has a well-structured healthcare system. This has helped the country with better access to the diagnostic tests that are available in the market. Diagnostic tests help early diagnostic of disease which can help the spread of these infectious diseases. As a result, this can noticed in the decreasing rate of infectious diseases over the years. However, the rate still remains high, which is expected to help the growth of this market
Majority of the Infectious disease diagnostics are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market growth.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Infectious Diseases
4.2.2 Shift in Focus From Centralized Laboratories to Decentralized Point-Of-Care Testing
4.2.3 Research on Infectious Disease Diagnostics
4.3 Market Restraints
4.3.1 Inadequate Reimbursements
4.3.2 Rising Healthcare Costs Limiting the Use of Novel Diagnostic Techniques
4.4 Porters Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Application
5.1.2 Human Immunodeficiency Virus (HIV)
5.1.3 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
5.1.4 Hospital-Acquired Infections
5.1.5 Human Papillomavirus (HPV)
5.1.6 Tuberculosis (TB)
5.1.8 Other Infectious Diseases
5.2 By Product
5.2.1 Assays, Kits, & Reagents
5.2.3 Services & Software
5.3 By Technology
5.3.1 Polymerase Chain Reaction (PCR)
5.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.4 DNA Microarray
5.3.5 Clinical Microbiology
5.3.6 DNA Sequencing & Next-Generation Sequencing (NGS)
5.4.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle-East and Africa
5.4.5 South America
188.8.131.52 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Biomérieux SA
6.1.2 Abbott Laboratories
6.1.3 Becton, Dickinson and Company
6.1.4 Bio-Rad Laboratories
6.1.5 Danaher Corporation
6.1.6 F. Hoffmann-La Roche AG
6.1.7 Siemens Healthineers
6.1.8 Thermo Fisher Scientific
6.1.9 Quidel Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.